Results 41 to 50 of about 29,160 (204)
Neglected Mycoses in Brazil: A Population‐Based Study of Mortality and In‐Hospital Mortality Over 25 Years
Mycoses, Volume 69, Issue 2, February 2026.ABSTRACT Objective
To describe the epidemiology, associated factors, spatial distribution, and temporal trends of mortality and in‐hospital mortality related to systemic mycoses in Brazil, 2000–2024. Methods
This is a nationwide ecological study combining temporal and spatial analyses using death certificates (DC; underlying and/or associated causes ...Anderson Fuentes Ferreira, Jorg Heukelbach, Eliana Amorim de Souza, Maria Aparecida Shikanai‐Yasuda, Lisandra Serra Damasceno, Fernanda Dockhorn Costa, Terezinha do Menino Jesus Silva Leitão, Helia Kawa, Alberto Novaes Ramos Jr. +8 morewiley +1 more sourceSofosbuvir : the hepatitis C patients' hope [PDF]
, 2016 Monografia realizada no âmbito da unidade de Estágio Curricular do Mestrado Integrado em Ciências Farmacêuticas, apresentada à Faculdade de Farmácia da Universidade de CoimbraHepatitis C virus infection is a substantial health problem on a global scale. (Gi, Andreia Filipa Pintorcore Selection of Host Plasma Membrane Lipids by HIV‐1 Gag Protein
BioEssays, Volume 48, Issue 1, January 2026.Enrichment of sphingomyelin in the HIV‐1 envelope arises from Gag binding to PI(4,5)P2, which triggers reorganization of plasma membrane sphingomyelin/cholesterol domains through unknown mechanisms. We propose that cholesterol‐mediated interleaflet coupling between sphingomyelin and PI(4,5)P2, rather than interdigitation, underlies Gag‐induced lipid ...Nario Tomishige, Yves Mély, Toshihide Kobayashi +2 morewiley +1 more sourcePerceived disabling physical pain and suicidal ideation in aging people living with HIV cured of hepatitis C: A multi‐center survey in France (ANRS CO13 HEPAVIH)
HIV Medicine, Volume 27, Issue 1, Page 106-119, January 2026.Abstract Introduction
Suicidal ideation (SI) is highly prevalent among people living with HIV (PWH) and those with chronic hepatitis C virus (HCV) infection. Individuals with long‐term HIV–HCV co‐infection face specific health challenges, including heightened physical pain.Tangui Barré, Clémence Ramier, Camelia Protopopescu, Philippe Sogni, Karine Ory, Tounes Saidi, Sophie Abgrall, Sylvie Brégigeon‐Ronot, Patrizia Carrieri, Fabienne Marcellin, the ANRS CO13 HEPAVIH Study Group, D. Salmon, L. Wittkop, P. Sogni, P. Carrieri, B. Spire, K. Ory, P. Trimoulet, J. Izopet, L. Serfaty, L. Alric, M. A. Valantin, G. Pialoux, J. Chas, K. Barange, A. Naqvi, E. Rosenthal, A. Bicart‐See, O. Bouchaud, A. Gervais, C. Lascoux‐Combe, C. Goujard, K. Lacombe, C. Duvivier, D. Neau, P. Morlat, F. Bani‐Sadr, F. Boufassa, C. Solas, H. Fontaine, L. Piroth, A. Simon, D. Zucman, F. Boué, P. Miailhes, E. Billaud, H. Aumaître, D. Rey, G. Peytavin, O. Zaeglel‐Faucher, D. Salmon, R. Usubillaga, P. Sogni, B. Bienvenu, O. Launay‐Puybasset, C. Bernasconi, A. Brunet, B. Silbermann, H. Boucher, F. Rollot, O. Zak Dit Zbar, S. Pol, C. Le Jeunne‐Ballif, P. Louergue, H. Mehawej, L. Merine‐Belardi, F. Almasi, N. Benammar, L. Alagna, S. Chaussade, L. Guillevin, B. Terris, C. Norgeux, C. Katlama, M. A. Valantin, H. Stitou, F. Caby, L. Paris, L. Schneider, R. Tubiana, A. Simon, L. Roudière, O. Benveniste, G. Breton, M. Bonmarchand, M. Kirstetter, F. Charlotte, F. Capron, V. Calvez, V. Thibaut, C. Soulie, B. Abdi, S. Lambert‐Niclot, S. Bregigeon‐Ronot, O. Zaegel‐Faucher, H. Laroche, A. Menard, E. Gaubert‐Marechal, S. Thirée, C. Tamalet, C. Hakimi, J. C. Poluzzi, C. Solas, G. Pialoux, J. Chas, L. Lassel, T. Lyavanc, S. Le Nagat, L. Slama, A. Canesti, P. Callard, B. Bachour, L. Alric, N. Sigur, D. Bonnet, M. Guivarch, K. Barange, J. M. Peron, P. Massip, L. Cuzin, M. Obada, E. Bonnet, M. Alvarez, E. Labau, M. Mularczyk, N. Bourdoncle, J. Penecy, L. Porte, F. Busato, S. Khatibi, J. Bernard, J. Selves, F. Larroquette, V. Ferrer, J. Chiabrandon, E. Rosenthal, C. Pradier, V. Mondain, P. Dellamonica, P. M. Roger, S. Ferrando, C. Ceppi, A. Naqvi, V. Rio, B. Dunais, B. Prouvost, F. De Salvadore‐Guillouet, I. Prebost, J. Durant, P. Pugliese, J. F. Michels, M. C. Saint‐Paul, C. Partouche, K. Nerini, O. Bouchaud, S. Abgrall, I. Zamord, F. Bidegain, M. Azghay, C. Rouyer, M. Tatay, F. Mechai, A. Martin, Y. Baazia, V. Iwaka‐Bande, A. Gerber, A. Bicart‐See, D. Garipuy, M. J. Ferro‐Collados, F. Gaches, F. Abravanel, F. Larroquette, J. Chiabrandon, A. Gervais, Y. Yazdanpanah, D. Henin, M. Bertine, M. Onambele, G. Peytavin, C. Lascoux‐Combe, T. Kandel, C. Pintado, J. M. Molina, C. Gatey, S. Gallien, W. Rozenbaum, M. Lafaurie, A. L. Munier, D. Ponscarme, M. Previllon, N. Colin De Verdière, M. G. Tateo, P. Palmer, A. Gabassi, R. Amarsy, M. C. Mazeron, K. Lacombe, J. Krause, D. Wendum, D. Fofana, C. Goujard, Y. Quertainmont, E. Teicher, L. Escaut, O. Derradji, C. Pallier, F. Veillet, L. Mouna, O. Lortholary, C. Duvivier, C. Rouzaud, M. Shoai Tehrani, S. Boucly, G. Obenga, J. P. Viard, E. Gardiennet, A. Mélard, D. Neau, A. Ochoa, E. Blanchard, C. Cazanave, M. Dupon, H. Dutronc, F. Dauchy, H. Wille, P. Bioulac‐Sage, P. Trimoulet, P. Morlat, D. Lacoste, F. Bonnet, N. Bernard, M. Hessamfar, F. Paccalin, C. Martell, M. C. Pertusa, M. Vandenhende, P. Mercié, T. Pistone, M. C. Receveur, M. Méchain, P. Duffau, C. Rivoisy, I. Faure, D. Malvy, J. Roger‐Schmeltz, D. Dondia, P. Bioulac‐Sage, P. Trimoulet, J. L. Pellegrin, E. Lazzaro, P. Bioulac‐Sage, P. Trimoulet, D. Zucman, C. Majerholc, J. E. Kahn, S. Hilaire, M. Brollo, F. Boué, S. Abgrall, J. Polo Devoto, I. Kansau, V. Chambrin, C. Pignon, C. Gatey, M. Favier, C. Deback, C. Vauloup, C. Pailler, F. Veillet, L. Mouna, J. L. Lopez Zaragoza, Y. Lévy, J. D. Lelièvre, A. S. Lascaux, S. Scerra, M. Bouvier‐Alias, E. Billaud, F. Raffi, C. Allavena, V. Reliquet, D. Boutoille, C. Biron, M. Lefebvre, N. Hall, S. Bouchez, C. Bernaud, O. Mounoury, A. Rodallec, L. Le Guen, P. Miailhes, D. Peyramond, C. Chidiac, F. Ader, F. Biron, A. Boibieux, L. Cotte, T. Ferry, T. Perpoint, M. Amiri, F. Valour, J. Koffi, F. Zoulim, F. Bailly, P. Lack, M. Maynard, S. Radenne, C. Augustin‐Normand, E. Vassel, T. T. Le‐Thi, L. Piroth, P. Chavanet, M. Duong Van Huyen, M. Buisson, A. Waldner‐Combernoux, S. Mahy, A. Fillion, H. Aumaître, M. Jean, A. Eden, M. Medus, M. Saada, S. Gaba, F. Bani‐Sadr, D. Lambert, Y. Nguyen, J. L. Berger, C. Rouger, V. Brodard, D Rey, M. Partasani, C. Cheneau, M. Priester, C. Bernard‐Henry, E. de Mautort, A. Ertle, F. Jegou, A. Fush, P. Gantner, S. Fafi‐Kremer, L. Pinheiro, F. Roustand, I. Kmiec, L. Traore, S. Le Puil, M. G. Tateo, S. Benothame, C. Pomes, C. Louisin, M. Mole, A. Adda, P. Thibaut, S. Poirier, R. Ben Rayana, M. P. Pietri, V. Le Baut, Y. Cuvillier, M. Alabatanah, F. Barret, F. Juster, C. Chesnel, D. Beniken, M. Sebire‐Le Cam, R. Monard, F. Badji, S. Caldato, T. Rojas Rojas, A. S. Ritleng, A. Ivanova, L. Chalal, Z. Julia, M. Cavellec, C. Chevalier, E. Paredes‐Manyari, S. Breau, N. Boughdiri, P. Fischer, C. Charles, S. Ogoudjobi, C. Brochier, V. Thoirain‐Galvan, L. Traore, S. Chaussee, S. Benothmane, A. Sondro, O. Camou, V. Godard, M. Kai, C. Gilbert, M. Pailler, L. Merchadou, L. Esterle, K. Ory, S. Gillet‐Rousseau, C. Khan, L. Abbad, M. Chalouni, V. Conte, F. Marcellin, R. Knight, M. Mora, C. Protopopescu, P. Roux, T. Barré +402 morewiley +1 more sourceLong‐term risk and predictors of high‐risk human papillomavirus persistence after thermal ablation amongst women living with HIV in West Africa
HIV Medicine, Volume 26, Issue 12, Page 1950-1962, December 2025.Abstract Introduction
Mounting evidence supports the use of thermal ablation in women positively screened with high‐risk Human Papillomaviruses (hrHPV) but limited data are available on the long‐term post‐treatment outcomes in women living with HIV (WLHIV).Simon Boni, Pierre Debaudrap, Firmin N. Kabore, Evelyne Kasile‐Pooda, Armel Poda, Belarsi Ouattara, Eugene Messou, Brahima Doukoure, Antoine Jaquet, Apollinaire Horo, on behalf IeDEA West Africa Collaboration +10 morewiley +1 more sourceMarcadores preditivos para infecção do vírus da hepatite C em presidiários brasileiros [PDF]
, 2009 Hepatitis C virus (HCV) infection has quite high prevalence in the prison system, reaching rates of up to 40%. This survey aimed to estimate the prevalence of HCV infection and evaluate risk factors for this exposure among male inmates at the Ribeirão ...COELHO, Harnoldo Colares, FIGUEIREDO, José Fernando de Castro, MIGUEL, Juliana Custódio, OLIVEIRA, Maria de Lourdes Aguiar, OLIVEIRA, Sabrina Alberti Nóbrega de, PASSOS, Afonso Dinis Costa, PERDONÁ, Gleici Castro +6 morecore +2 more sourcesHigh Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam
Journal of Viral Hepatitis, Volume 32, Issue 11, November 2025.ABSTRACT
People who inject drugs (PWID) are highly affected by hepatitis C (HCV) worldwide, particularly in low‐ and middle‐income countries (LMICs), where access to addiction services is often limited. Reducing the burden of HCV, as promoted by WHO, requires effective interventions in this high‐risk population.Didier Laureillard, Nguyen Thanh Binh, Vu Hai Vinh, Tran Thi Hong, Catherine Quillet, Nham Thi Tuyet Thanh, Roselyne Vallo, Bach Thi Nhu Quynh, Jean Pierre Moles, Khuat Thi Hai Oanh, Duong Thi Huong, Delphine Rapoud, Jonathan Feelemyer, Laurent Michel, Peter Vickerman, Hannah Fraser, Laurence Weiss, Maud Lemoine, Karine Lacombe, Don Des Jarlais, Pham Minh Khue, Nicolas Nagot +21 morewiley +1 more source
